Literature DB >> 22045479

Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease.

Maria E Soto1, Marion Secher, Sophie Gillette-Guyonnet, Gabor Abellan van Kan, Sandrine Andrieu, Fati Nourhashemi, Yves Rolland, Bruno Vellas.   

Abstract

Weight loss is a frequent complication of Alzheimer's disease (AD) and a strong predictor of adverse outcomes in patients suffering from this disease. The aim of this study was to determine whether weight loss was a predictor of rapid cognitive decline (RCD) in AD. Four hundred fourteen community-dwelling ambulatory patients with a diagnosis of probable AD and a Mini-Mental State Examination (MMSE) score between 10 and 26 from the REAL.FR (REseau sur la maladie d'ALzheimer FRançais) cohort were studied and followed up during 4 years. Patients were classified in 2 groups according to weight loss defined by a loss of 4% or more during the first year of follow-up. RCD was defined as the loss of 3 points or more in MMSE over 6 months. The incidence of RCD was determined among both groups over the last 3 years of follow-up. MMSE, Katz's Activity of Daily Living scale, Mini-Nutritional Assessment scale, co-morbidities, behavioral and psychological symptoms of dementia, medication, level of education, living arrangement, and caregiver's burden were assessed every 6 months. Eighty-seven patients (21.0%) lost 4% or more of their initial weight during the first year. The incidence of RCD for all patients was 57.6 (95% confidence interval (CI) = 51.6-64.8) per 100 person-year (median follow-up of 15.1 months). In Cox proportional hazards models, after controlling for potential confounders, weight loss was a significant predictor factor of RCD (adjusted hazard ratio (HR) = 1.50, 95% CI = 1.04-2.17). In conclusion, weight loss predicted RCD in this cohort. Whether the prevention of weight loss (by improving nutritional status) impacts cognitive decline remains an open question.

Entities:  

Mesh:

Year:  2012        PMID: 22045479     DOI: 10.3233/JAD-2011-110713

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  28 in total

Review 1.  HDL-cholesterol and apolipoproteins in relation to dementia.

Authors:  Manja Koch; Majken K Jensen
Journal:  Curr Opin Lipidol       Date:  2016-02       Impact factor: 4.776

2.  Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer disease.

Authors:  Lilah M Besser; Dawn P Gill; Sarah E Monsell; Willa Brenowitz; Dana H Meranus; Walter Kukull; Deborah R Gustafson
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Jan-Mar       Impact factor: 2.703

Review 3.  Weight Loss in Patients with Dementia: Considering the Potential Impact of Pharmacotherapy.

Authors:  Bart A A Franx; Ilse A C Arnoldussen; Amanda J Kiliaan; Deborah R Gustafson
Journal:  Drugs Aging       Date:  2017-06       Impact factor: 3.923

4.  Nutritional Guidance Improves Nutrient Intake and Quality of Life, and May Prevent Falls in Aged Persons with Alzheimer Disease Living with a Spouse (NuAD Trial).

Authors:  M H Suominen; T M Puranen; S K Jyväkorpi; U Eloniemi-Sulkava; H Kautiainen; U Siljamäki-Ojansuu; K H Pitkalä
Journal:  J Nutr Health Aging       Date:  2015-11       Impact factor: 4.075

5.  Change in body mass index before and after Alzheimer's disease onset.

Authors:  Yian Gu; Nikolaos Scarmeas; Stephanie Cosentino; Jason Brandt; Marilyn Albert; Deborah Blacker; Bruno Dubois; Yaakov Stern
Journal:  Curr Alzheimer Res       Date:  2014-05       Impact factor: 3.498

6.  Malnutrition in community-dwelling adults with dementia (NutriAlz Trial).

Authors:  M Roqué; A Salvà; B Vellas
Journal:  J Nutr Health Aging       Date:  2013-04       Impact factor: 4.075

7.  Clinical features, outcome and cost of hyponatremia-associated admission and hospitalization in elderly and very elderly patients: a single-center experience in Turkey.

Authors:  K Turgutalp; O Ozhan; E Gok Oguz; M Horoz; A Camsari; A Yilmaz; A Kiykim; M Arici
Journal:  Int Urol Nephrol       Date:  2012-10-11       Impact factor: 2.370

8.  Changes in Nutritional Status after Deep Brain Stimulation of the Nucleus Basalis of Meynert in Alzheimer's Disease--Results of a Phase I Study.

Authors:  M Noreik; J Kuhn; K Hardenacke; D Lenartz; A Bauer; C P Bührle; P Häussermann; M Hellmich; J Klosterkötter; J Wiltfang; M Maarouf; H-J Freund; V Visser-Vandewalle; V Sturm; R-J Schulz
Journal:  J Nutr Health Aging       Date:  2015-10       Impact factor: 4.075

9.  A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer's Disease, the 5XFAD Mouse.

Authors:  Antonio J López-Gambero; Cristina Rosell-Valle; Dina Medina-Vera; Juan Antonio Navarro; Antonio Vargas; Patricia Rivera; Carlos Sanjuan; Fernando Rodríguez de Fonseca; Juan Suárez
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

10.  Community-acquired hypernatremia in elderly and very elderly patients admitted to the hospital: clinical characteristics and outcomes.

Authors:  Kenan Turgutalp; Onur Özhan; Ebru Gök Oğuz; Arda Yılmaz; Mehmet Horoz; Ilter Helvacı; Ahmet Kiykim
Journal:  Med Sci Monit       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.